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Background: Dementia-speciﬁc and proxy-completed preference-based measures have been proposed for use in intervention
studies involving people living in residential care, in instances where generic, self-reported preference-based measures have
been deemed inappropriate.
Objective: This study was conducted to investigate the construct validity, criterion validity, and responsiveness of DEMQOL-
Proxy-U and of self- and proxy-completed EQ-5D-5L.
Methods: The analysis used a 3-wave, individual-level data set of 1004 people living with dementia in residential care that
included self-completed EQ-5D-5L and formal-carer and informal-carer proxy-completed EQ-5D-5L and DEMQOL-Proxy-U
utility values, in addition to other nonutility cognitive measures (Functional Assessment Staging [FAST], Clinical Dementia
Rating [CDR], Cohen-Mansﬁeld Agitation Inventory [CMAI]) and health-related quality of life (HRQOL) measures (nursing
home version of the Quality of Life with Alzheimer’s disease scale [QOL-AD-NH], Quality of Life in Late-Stage Dementia
[QUALID] scale). Construct validity, criterion validity, and responsiveness were assessed using correlation, Bland-Altman
plots, and panel data regression models.
Results: Self-completed EQ-5D-5L failed to reﬂect clinically important differences and changes in FAST, CDR, and CMAI but did
capture the resident’s own view of HRQOL (QOL-AD-NH). As dementia severity increased, collection of EQ-5D-5L-proxy and
DEMQOL-Proxy-U data was more feasible than collection of self-completed EQ-5D-5L. These formal-carer and informal-carer
proxy measures also better reﬂected changes in FAST, CDR, and CMAI but did not capture the resident’s own view of HRQOL
(QOL-AD-NH), despite adequately capturing the proxy’s own view of the resident’s HRQOL (QUALID). This indicates
discrepancies between a proxy’s view and resident’s view of the impact that tangible declines in health, cognition, or
functional abilities have on HRQOL. The EQ-5D-5L-proxy and DEMQOL-Proxy-U were generally poor substitutes.
Regardless of which proxy completed it, the EQ-5D-5L-proxy was typically more responsive than the DEMQOL-Proxy-U to
changes in CDR, FAST, and CMAI, indicating that use of the DEMQOL-Proxy-U is not always justiﬁed.
Conclusion: Disparities in the measurement properties of different utility measures mean that choices about how to measure
utility in trials could affect economic evaluation outcomes and hence how resources are allocated for dementia care.
Keywords: dementia, DEMQOL, EQ-5D, preference-based measures.
VALUE HEALTH. 2019; -(-):-–-Introduction
The National Institute for Health and Care Excellence (NICE)
Technology Assessment reference case states that health-related
quality of life (HRQOL) should be measured using the self-
completed EQ-5D, which has been shown to be valid, reliable,
and responsive across numerous disease areas.1 However, NICE
may consider other preference-based measures (PBMs) to bess correspondence to: Adam Martin, PhD, Academic Unit of Health Econom
a.martin1@leeds.ac.uk
15 - see front matter Copyright ª 2019, ISPOR–The Professional Society for
cess article under the CC BY-NC-ND license (http://creativecommons.org/lic
doi.org/10.1016/j.jval.2019.07.002informative, including when the self-completed EQ-5D has weak
construct validity within a particular patient population. In these
cases, proxy-completed or condition-speciﬁc utility measures may
be used as supplementary evidence.
For people with dementia, proxy-completed PBMs may be
justiﬁed owing to problems with communication recall, time
perception, and insight.2 One study showed almost half (48%) of
respondents with dementia self-reported having no problems onics, Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9TJ, UK.
Health Economics and Outcomes Research. Published by Elsevier Inc. This is an
enses/by-nc-nd/4.0/).
2 VALUE IN HEALTH - 2019any EQ-5D dimension (ie, “perfect health”),3 which seemed un-
likely to accurately reﬂect the respondents’ true health state, given
the instrument’s assessment of such areas as mobility and pain.
However, proxy assessors can have different perceptions of an-
other’s capabilities and health state,2,4 perhaps particularly for
more unobservable or subjective dimensions (eg, pain or anxiety/
depression vs functional ability), and exhibit additional sources of
bias that could differ between individuals. For example, a relative’s
response might reﬂect additional emotional burden when
compared with formal or employed carers. Ethical issues arise if
the views of individuals about their own HRQOL differ from the
views of their proxies, especially if these affect economic evalua-
tion outcomes and hence resource allocation decisions affecting
them.
Dementia-speciﬁc PBMs are designed to capture physical
function and cognitive changes that are common in dementia but
poorly reﬂected in generic measures and have been valued by
general population samples, including in Australia and the UK.5-7
Dementia researchers thus face a relatively unique challenge in
choosing an appropriate measure (generic vs condition-speciﬁc)
as well as respondent (self vs informal carer vs formal carer).
This study’s main purpose was to examine and compare the
measurement properties of proxy-completed versus self-
completed PBMs and generic versus dementia-speciﬁc PBMs.
Analyses of construct validity, criterion validity, and respon-
siveness will aid decisions about how best to capture utility
(and change in utility) and thus support the interpretation and
design of health economic analyses involving people with
dementia.
This study used a large, 3-wave, individual-level data set of
people with dementia living in care homes collected during a
multisite trial (Enhancing Person Centred Care In Care Homes
Trial).8 The data include a rich combination of resident-completed,
proxy-reported, generic, and dementia-speciﬁc PBMs in addition
to other non-PBM cognitive and HRQOL measures. Although two
Australian4,9 studies have compared the included PBMs, this UK-
based study used larger sample sizes, compared more cognitive
health and HRQOL measures, and involved modeling temporal
within-individual changes, using panel data regression
techniques.Methods
Data Set
Residents (n = 1004) were recruited from 50 UK care homes in
an open cohort cluster randomized controlled trial that evaluated
Dementia Care MappingTM, an intervention that aims to reduce
agitation and improve HRQOL for people with dementia.8,10 Res-
idents (supported by researchers), a formal-carer proxy assessor
(member of care home staff), and, where possible, a further
informal-carer proxy assessor (a friend or relative who visited at
least fortnightly) were invited to complete PBMs and other
questionnaires at 1 (n = 425), 2 (n = 173), or 3 (n = 406) time points
(when they entered the trial and at up to 2 follow-ups) between
May 2014 and May 2017. The mean time between time points was
252 days (SD 55.9). Not all residents were assessed at all 3 time
points mainly owing to death (n = 281), recruitment after trial
baseline (n = 261), or leaving the care home (n = 47) (see Appendix
Fig. 1 in Supplementary Materials found at https://doi.org/10.1016/
j.jval.2019.07.002). Formal-carer proxies were replaced whenever
they became unavailable (eg, because of staff turnover, sickness, or
other absence). Not all residents had an informal-carer proxyeither because their recruitment ceased in this study prior to the
third time point or owing to a lack of regular visitors who wished
to participate in the study.
Description of Variables
Table 1 summaries the resident- and proxy-completed ques-
tionnaires used in this study. Residents’ health status was self-
reported using the 5-dimension EQ-5D-5L and proxy-reported
using the EQ-5D-5L-proxy (version 1)11 and the 31-item
DEMQOL-Proxy.5 UK scoring algorithms were used to convert
these to the EQ-5D-5L and DEMQOL-Proxy-U (using 4 items from
the DEMQOL-Proxy—namely, appearance, memory, negative
emotion, and positive emotion) utility scores.5,12
Residents’ degree of cognitive and functional impairment was
assessed by formal-carer proxies using the following:
 Functional Assessment Staging (FAST), which scores functional
symptoms of dementia from 1 (“normal adult” without difﬁ-
culties) to 7 (“severe dementia,” eg, daily speech limited to #5
words).13 In this study, scores #4 (ie, “mild dementia,” eg, difﬁ-
culties planning dinner for guests) were combined into a single
category because recruitment to the trial required a score $4.
 Clinical Dementia Rating (CDR) scale, which assesses cognitive
impairment in 6 categories (eg, related to memory or orienta-
tion) and generates a single severity score ranging from
0 (“normal adult”) to 3 (“severe dementia”).14
 Cohen-Mansﬁeld Agitation Inventory (CMAI), which measures
the frequency of 29 behaviors typically associated with agita-
tion on a 7-point scale (from ”never” to “several times an hour”)
and generates a single score ranging from 29 to 203 (where
changes $8 can be considered clinically meaningful).15
Residents’ HRQOL was self-reported using the 15-item nursing
home version of the Quality of Life in Alzheimer’s Disease scale
(QOL-AD-NH), which scores items including energy, mood, living
situation, and memory on 4-point scales, and by both proxies
using the 11-item Quality of Life in Late-Stage Dementia (QUALID)
measure, which scores items including smiling, sadness, and
enjoyment of interaction with others on 6-point scales.16 In both
cases, the sum of item-level scores generates a single measure on
a 45-point scale.
Statistical Analysis
Descriptive analysis
Summary statistics (including the extent of missing data) were
reported for variables of interest. Selected frequency distributions
were examined using histograms.
Construct validity
Construct validity was examined by comparing utility scores.
First, pairs of utility scores generated by different PBMs completed
by the same proxy respondent at the same time point were
compared (eg, informal carers’ EQ-5D-5L-proxy and DEMQOL-
Proxy-U responses) using Spearman’s rank-order correlation
(where correlation ,0.3 was considered weak, 0.3 to ,0.5 mod-
erate, 0.5 to ,0.6 strong, and $0.6 very strong4) and Bland-
Altman plots (differences between 2 utility values generated by
2 different PBMs plotted against the mean of the utility values).
Second, utility scores generated from the same PBM completed by
different respondents at the same time point were compared (eg,
informal-carer EQ-5D-5L-proxy vs formal-carer EQ-5D-5L-proxy
or resident-completed EQ-5D-5L) using Spearman’s rank-order
Table 1. Description of questionnaires used in the study.
Description of questionnaire Description
of variable used in this
analysis
What it
measures
Resident Formal-
carer
proxy
Informal-
carer
proxy
Perspective
adopted by
proxies
Timescale Conversion of
questionnaire
data to
numerical
score
Range of
possible
values
Preference based measures (increasing in quality of life)
EQ-5D-5L Five dimensions:
mobility, self-
care, usual
activities, pain or
discomfort, and
anxiety or
depression
U U* U* Their own
opinion of the
resident’s health
status
Resident’s
immediate
situation—ie,
their “health
today”
Index utility
score generated
using a general
population
valuation of the
health states12
20.285 to 1
DEMQOL-
Proxy
31 items
including factors
related to
appearance,
memory, positive
emotions, and
negative
emotions
7 U U Their view of
what they think
residents would
provide
themselves if
they were willing
and able
How the
resident felt
during the past
week
Relevant
components of
the DEMQOL-
Proxy converted
to an index utility
score (DEMQOL-
Proxy-U) using a
general
population
valuation of the
health states5
0.363 to 0.937
Cognitive measures (increasing in severity of dementia or agitation)
FAST Functional
severity of
dementia on a
scale from 1 (a
“normal” adult
with no
difﬁculties) to 7
(“severe
dementia”)
7 U 7 Not speciﬁed Not speciﬁed FAST scores #4
were combined
into a single
category (due to
small sample
sizes where FAST
score ,4)
Four categories:
#4, 5, 6, 7
CDR Cognitive
impairment on 6
cognitive
categories
7 U 7 Not speciﬁed Not speciﬁed Converted to an
overall severity
rating ranging
from 0 to 3.
Ratings of 0, 0.5,
and 1 were
combined in this
analysis (owing
to small sample
sizes where
CDR,1)
Three
categories:
#1, 2, 3
CMAI Frequency of 29
agitated or
aggressive
behaviors on a
7-point scale
ranging from 1
(“never”) to 7
(“several times
an hour”)
7 U 7 Not speciﬁed Based on
observations
during the
previous
fortnight
Frequency scores
are summed
29 to 203
Other HRQOL measures (increasing in quality of life)
QOL-AD-NH 15 aspects of
quality of life
including
perception of
energy, mood,
living situation,
and memory on
a 4-point scale
(poor, fair, good,
excellent)
U 7 7 N/A N/A Individual scores
are summed
45-point scale
continued on next page
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Table 1. Continued
Description of questionnaire Description
of variable used in this
analysis
What it
measures
Resident Formal-
carer
proxy
Informal-
carer
proxy
Perspective
adopted by
proxies
Timescale Conversion of
questionnaire
data to
numerical
score
Range of
possible
values
QUALID Presence and
frequency of 11
quality of life
indicators
including smiling,
appearing sad,
crying, and
enjoying eating
7 U U Not speciﬁed Based on
observations
during the
previous week
Individual
scores are
summed
45-point scale†
Note. Except for FAST and CDR, all variables were treated as continuous variables.
CDR indicates Clinical Dementia Rating; CMAI, Cohen-Mansﬁeld Agitation Inventory; FAST, Functional Assessment Staging; HRQOL, health-related quality of life; N/A, not
applicable; QOL-AD-NH, nursing home version of the Quality of Life in Alzheimer’s Disease scale; QUALID, Quality of Life in Late-Stage Dementia scale.
*EQ-5D-5L proxy version 1.11
†To aid interpretation and for consistency with the QOL-AD-NH, but contrary to general usage, the QUALID scores were reversed in this study so that higher scores
represented improved quality of life.
4 VALUE IN HEALTH - 2019correlation and Bland-Altman plots (ﬁrst, differences between 2
utility values recorded at the same time point were plotted against
the mean, and second, differences between the change in utility
values between 2 time points were plotted against the mean at
the ﬁrst time point).
Criterion validity
Criterion validity was examined by comparing utility scores
and nonutility measures. Associations between each PBM and the
non-PBM cognitive (FAST, CDR, and CMAI) and HRQOL measures
(QUALID and QOL-AD-NH) (described earlier) were examined at
the same time point using Spearman’s rank-order correlation and
panel data regression models with random effects (model 1): In
the absence of evidence that other regression models would
perform better in a dementia population, all regression analyses in
this study used linear model speciﬁcations.
Model 1: Utilityi;t ¼b11b2healthi;t1 εi;t ;
where utilityi,t is the utility score for each individual (i) at each
time point (t) for a particular PBM-respondent combination (n =
5), and healthi,t is a particular cognitive or HRQOL measure (n = 6)
(this was a single continuous variable, except for the FAST and CDR
scores, where a vector of categorical variables was created, with
least impaired states in the reference category). This enabled
model output comparisons across multiple outcome measures.
The model was run separately for each PBM-respondent
combination (n = 5) and cognitive or HRQOL variable (n = 6).
Missing data for particular utility scores meant sample sizes varied
in each analysis. A sensitivity analysis used a restricted sample of
observations where all 5 utility scores were completed.
The coefﬁcient of interest (b2) shows the association between
an additional unit of cognitive health or HRQOL (eg, a 1-unit
change in CMAI), or being in a particular health category
compared with the reference category (eg, FAST score 6 compared
with FAST score #4), and a particular utility score. We calculated
95% conﬁdence intervals and adjusted for multiple comparisons
using Bonferroni correction (n = 6 per outcome measure). Statis-
tically signiﬁcant b2 values indicated criterion validity.Responsiveness
The impact of changes in the cognitive or HRQOL measures (n =
6) on each utility score (n = 5) was evaluated using linear ﬁxed
effects panel data regression models (as model 1). The ﬁxed effects
approach means that only within-individual changes are included
in the analysis. Hence, statistically signiﬁcant b2 values were
deemed indicative of responsiveness.Results
Descriptive Statistics
The sample included 1989 observations from 1004 residents
and an average of 1.98 time points per resident (SD 0.91). Of these,
406 residents (40.4%) participated in the study at all 3 time points;
the remainder of the residents were in the study for only 1 (42.3%)
or 2 (17.2%) time points.
Residents ranged from 58.0 to 102.6 years of age on entering
the data set (mean = 85.5 yr). They were more likely female
(73.2%) than male and 3.3% had ethnic backgrounds other than
white British (see Table 2 for descriptive statistics, with selected
frequency distributions shown in Appendix Fig. 2 in the Supple-
mentary Materials found at https://doi.org/10.1016/j.jval.2019.07.
002).
PBMs
Sample sizes were largest for the formal-carer EQ-5D-5L-proxy
and DEMQOL-Proxy-U, with at least 1 observation for 1003 in-
dividuals (100%) (N = 1980 for EQ-5D-5L-proxy and N = 1983 for
DEMQOL-Proxy-U). Missing formal-carer–completed PBM data
were rare (15 instances) and due to partial questionnaire
completion (1-2 missing items, 13 instances) or noncompletion (2
instances).
At least 1 resident-reported EQ-5D-5L utility score was avail-
able for 558 individuals (56%) in the data set (N = 897, 45%), and of
the resident-reported EQ-5D-5L utility scores, there was an
average of 1.60 observations per individual. There were 67 in-
stances (3.4%) of partial completion (1-4 missing items) and 1025
Table 2. Descriptive statistics for performance-based measures and other cognitive and health-related quality of life measures.
Number of
observations
(N)
and % of all
observations
Number of
individuals
(n)
and % of all
observations
Number of
observations
per individual
Mean
value
Range Variation*
Overall Between
individuals
Within individuals
Performance-based measures (increasing in quality of life)
EQ-5D
Resident 897 (45.1%) 558 (55.6%) 1.607 0.861 20.092 to 1 0.175 0.163 0.087
Formal-carer 1980 (99.5%) 1003 (99.9%) 1.974 0.658 20.218 to 1 .241 0.221 0.118
Informal-carer 349 (17.5%) 184 (18.3%) 1.897 0.486 20.281 to 1 0.249 0.224 0.105
DEMQOL-Proxy-U
Formal-carer 1983 (99.7%) 1003 (99.9%) 1.977 0.751 0.363 to 0.937 0.117 0.100 0.071
Informal-carer 342 (17.5%) 184 (18.3%) 1.858 0.701 0.404 to 0.937 0.127 0.112 0.062
Cognitive measures (increasing in severity of dementia or agitation)
CMAI
Formal-carer 1964 (98.7%) 985 (98.1%) 1.994 45.114 29 to 129 16.570 15.518 7.693
FAST (categorical variable)
Formal-carer 1954 (98.2%) 994 (99.0%) 1.966 n/a 1 to 4 192 (9.83%) 162 (16.3%) 64.3%
5 156 (7.98%) 146 (14.7%) 56.05%
6 1165 (59.62%) 728 (73.2%) 82.07%
7 441 (22.57%) 278 (28.0%) 75.72%
CDR (categorical variable)
Formal-carer 1957 (98.4%) 987 (98.3%) 1.983 n/a 0 or 0.5 75 (3.8%) 70 (7.1%) 58.3%
1 450 (23.0%) 341 (34.6%) 69.6%
2 767 (39.2%) 539 (54.6%) 70.4%
3 665 (34.0%) 433 (43.9%) 76.1%
Other health-related quality of life measures (inceasing in quality of life)
QOL-AD-NH
Resident 665 (33.4%) 448 (44.6%) 1.484 42.466 17 to 60 5.793 5.667 2.666
QUALID
Formal-carer 1958 (98.4%) 987 (98.3%) 1.984 19.970 11 to 49 6.598 5.894 3.632
Informal-carer 360 (18.1%) 186 (18.5%) 1.935 22.162 11 to 44 7.499 6.955 3.211
CDR indicates Clinical Dementia Rating; CMAI, Cohen-Mansﬁeld Agitation Inventory; FAST, Functional Assessment Staging; QOL-AD-NH, nursing home version of the
Quality of Life in Alzheimer’s Disease scale; QUALID, Quality of Life in Late-Stage Dementia scale.
*For continuous variables, these 3 columns show standard deviation. For categorical variables (FAST and CDR), these 3 columns show the following:
 For the “Overall” column: The number of observations in a given category and as a percentage of all observations (total = 100%).
 For the “Between individuals" column: The number of individuals that were ever in a given category (eg, 70 individuals ever had CDR score = 0 or 0.5) and as a
percentage of all individuals (eg, 7.1% of all individuals ever had CDR score = 0 or 0.5).
 For the “Within individuals” column: The fraction of time that individuals were in a given category, conditional on ever having been in that category (eg, conditional on
having ever had a CDR score=0 or 0.5, 58.3% of an individual’s observations were in that category).
-- 5instances (52%) of noncompletion (with reasons recorded in 1006
instances, typically related to the resident being unable or reluc-
tant to communicate with the researcher). The likelihood of
noncompletion increased with dementia severity, rising, for
example, from 17% of observations in the “normal or very
mild dementia” CDR category to 83% in the “severe dementia”
category.
Sample sizes were smallest for the informal-carer PBMs (n =
184 individuals [18.3% of all individuals], with N = 349 EQ-5D-5L-
proxy observations and N = 342 DEMQOL-Proxy-U observations)
mainly owing to fewer eligible informal-carer proxies being
recruited, but also due to 1-3 missing items on the PBM ques-
tionnaire (33 instances).
The mean value of DEMQOL-Proxy-U scores was higher than
the mean value of EQ-5D-5L-proxy scores (ranging from 0.486
for informal-carer EQ-5D-5L-proxy to 0.751 for formal-carer
DEMQOL-Proxy-U), with a lower standard deviation. The
resident-completed EQ-5D-5L had the highest mean utility score
(0.861). Across all PBM respondent combinations, within-
individual deviation was smaller than deviation between-
individuals.Construct Validity
Appendix Figures 3-5 show the Spearman’s rank order corre-
lation coefﬁcients and Bland-Altman plots. Appendix Figures 6-9
show comparisons between over-time changes in the resident-
completed and 2 proxy-completed EQ-5D-5L utility scores.
(These ﬁgures appear in the Supplementary Materials found at
https://doi.org/10.1016/j.jval.2019.07.002.)
Different PBMs completed by the same proxy
respondent
Correlation between informal-carer–completed utility scores
was moderate (rho = 0.386) and between formal-carer–completed
utility scores was weak (0.191) (Appendix Fig. 3[i] and [ii] in Sup-
plementaryMaterials found at https://doi.org/10.1016/j.jval.2019.07.
002). For both proxies, the DEMQOL-Proxy-U scores were higher on
average than the EQ-5D-5L-proxy scores, although discrepancies
between scoreswere lower at higher utility levels. Mean differences
between EQ-5D-5L-proxy and DEMQOL-Proxy-U utility scores were
greater among informal-carer (0.214) than formal-carer (0.092)
proxies, with smaller discrepancies at higher utility levels.
Figure 1. Associations between utility scores and nonutility cognitive and health-related quality of life measures (criterion validity).
Figure shows the coefﬁcients fo b2 r model 1 run for each combination of utility (n = 5) and non-utility cognitive measures (n = 3). The FAST and CDR scores are cat-
egorical variables. CDR 0, 0.5 and 1 are in the reference category. FAST #4 is in the reference category. The CMAI (range 29-203), QOL-AD and QOL-AD-NH (45 point
scales) scores are continuous variables. The thicker conﬁdence intervals indicate P , .05. The thinner conﬁdence intervals are after adjustment for multiple hypothesis
testing using Bonferroni correction. CDR indicates Clinical Dementia Rating; CMAI, Cohen-Mansﬁeld Agitation Inventory; FAST, Functional Assessment Staging; QOL-AD-
NH, nursing home version of the Quality of Life in Alzheimer’s disease scale; QUALID, Quality of Life in Late-Stage Dementia scale.
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Correlation between informal-carer and formal-carer proxy-
completed utility scores was strong for EQ-5D-5L (rho = 0.528)
and weak for DEMQOL-Proxy-U (0.088) (Appendix Fig. 3[iii]
and [iv] in Supplementary Materials found at https://doi.org/10.1
016/j.jval.2019.07.002). For both PBMs, formal-carer proxy-
completed scores were higher on average than the informal-carer
proxy-completed scores, although for EQ-5D-5L they were lower
at higher utility levels and for DEMQOL-Proxy-U the discrepancies
between scores were very small, especially at the highest and
lowest utility levels.
Correlation between formal-carer EQ-5D-5L-proxy and
resident-reported EQ-5D-5L utility scores was weaker (rho =
0.264) than that between informal-carer EQ-5D-5L-proxy and
resident-completed EQ-5D-5L utility scores (0.354) (Appendix
Figs. 4 and 5 in Supplementary Materials found at https://doi.
org/10.1016/j.jval.2019.07.002). In both cases, correlation (rho)
between the carer-reported EQ-5D-5L-proxy and resident-
reported EQ-5D-5L utility scores decreased, and mean differ-
ences increased, with dementia severity (CDR score). On
average, EQ-5D-5L-proxy scores were lower than the resident-
completed EQ-5D-5L scores (eg, mean difference of 20.118 for
formal carers and 20.275 for informal carers), with the greatest
discrepancies between utility scores at lower utility levels. On
average, over-time changes in utility were smaller for EQ-5D-5L-proxy respondent scores when compared with resident-
reported EQ-5D-5L scores, although there was considerable
heterogeneity between individuals (Appendix Figs. 6-9 in Sup-
plementary Materials found at https://doi.org/10.1016/j.jval.2019.
07.002).
Criterion Validity
Appendix Table 1 (in Supplementary Materials found at
https://doi.org/10.1016/j.jval.2019.07.002) shows the Spearman’s
rank-order correlation results. Figure 1 shows regression results
and Appendix Figure 10 (in Supplementary Materials found at
https://doi.org/10.1016/j.jval.2019.07.002) shows the sensitivity
analysis where data were complete for all 5 utility scores.
Cognitive measures
Relationship with resident-completed EQ-5D-5L
scores. No relationship was identiﬁed in either the Spear-
man’s rank or (Bonferroni adjusted) regression analysis between
the resident-completed EQ-5D-5L and the CDR or FAST measures.
Although before Bonferroni adjustment a statistically signiﬁcant
relationship was observed between the resident-completed EQ-
5D-5L and the CMAI measure, the effect size was very small (an
8-unit increase in CMAI, ie, increased agitation, was associated
with lower utility of 0.01).
Figure 2. Responsiveness of utility scores to changes in
nonutility cognitive measures.
Figure shows the b2 coefﬁcients for model 1 run for each combination of utility (n
= 5) and non-utility cognitive measures (n = 3). The FAST and CDR scores are
categorical variables. The b2 coefﬁcient for FAST score 5 is compared here to the
b2 coefﬁcient for FAST score 4, coefﬁcients for FAST score 6 are compared to
FAST score 5, and FAST score 7 is compared to FAST score 6. Similarly, CDR score
2 is compared to the reference category (i.e. CDR 0, 0.5 and 1), and CDR score 3 is
compared to CDR score 2. The CMAI (range 29-203) is a continuous variable. The
thicker conﬁdence intervals indicate P, .05. The thinner conﬁdence intervals are
after adjustment for multiple hypothesis testing using Bonferroni correction. The
responsiveness of utility scores to changes in non-utility HRQOL measures are
shown in Appendix Figure 11. CDR indicates Clinical Dementia Rating; CMAI,
Cohen-Mansﬁeld Agitation Inventory; FAST, functional assessment staging;
HRQOL, health-related quality of life.
-- 7Relationship with proxy-completed EQ-5D-5L
scores. The relationship between both EQ-5D-5L-proxy utility
scores and the FAST and CDR measures was shown by the
Spearman’s rank-order coefﬁcients to be moderate (ranging from
rho = 20.346 to 20.492) and, in the regression results, to be
statistically signiﬁcant and negative (with 1 exception). All
regression coefﬁcients increased in magnitude with dementia
severity (eg, for formal carers, the coefﬁcient for FAST score 7
was 20.323 compared with 20.177 for FAST score 6, both
compared to FAST score #4). The size of the coefﬁcients wasgenerally comparable for both proxies (eg, coefﬁcient for FAST
score 6 compared with FAST score 4 was 20.18 in the formal-
carer analysis and 20.16 in the informal-carer analysis).
The relationship between the formal-carer EQ-5D-5L-proxy
utility scores and the CMAI measure was statistically signiﬁcant in
the regression results with larger coefﬁcients than in the analyses
of other utility measures, including the analyses of informal-carer
EQ-5D-5L-proxy utility scores where coefﬁcients were not statis-
tically signiﬁcant.
Relationship with DEMQOL-Proxy-U scores. The rela-
tionship between both proxy-completed DEMQOL-Proxy-U utility
scores and the FAST and CDR measures was very weak in the
Spearman’s rank-order analysis. The only statistically signiﬁcant
effects observed in the regression analysis were the relationship
between formal-carer DEMQOL-Proxy-U score and the CDR
score, however the effect sizes were notably smaller than those
observed in the analyses of EQ-5D-5L-proxy scores completed
by the same proxy.
As with the EQ-5D-5L-proxy analyses, the relationship be-
tween the CMAI score and the formal-carer DEMQOL-Proxy-U
score was of a higher magnitude than the informal-carer DEM-
QOL-Proxy-U score, which was not statistically signiﬁcant.
Other HRQOL measures
The relationship between resident-reported QOL-AD-NH and
EQ-5D-5L was weak in the Spearman’s rank-order analysis (rho =
0.28), and in the regression analysis it was statistically signiﬁcant.
This contrasted with the ﬁnding of no relationship observed in the
Spearman’s rank-order analysis, and the ﬁnding of no statistically
signiﬁcant relationship observed in the regression analysis, be-
tween (resident-reported) QOL-AD-NH and the other 4 utility
measures.
Conversely, in the Spearman’s rank-order analysis, the formal-
carer–completed QUALID had a weak to moderate relationship
with all utility scores, except for the resident-reported EQ-5D-5L.
The informal-carer–completed QUALID also had a weak to mod-
erate relationship with both the informal-carer EQ-5D-5L-proxy
and DEMQOL-Proxy-U.
In the regression analysis, the QUALID scores had a statistically
signiﬁcant relationship with all utility scores. The magnitude of
the relationship between QUALID and a utility score was always
greater when the QUALID and utility score were completed by the
same proxy. For example, a 10-unit change in formal-carer QUALID
was associated with a 0.112 change in the formal-carer EQ-5D-5L-
proxy and a 0.083 change in the informal-carer EQ-5D-5L-proxy.
Responsiveness
Figures 2 and Appendix Figure 11 (in the Supplementary Ma-
terials found at https://doi.org/10.1016/j.jval.2019.07.002) show
the coefﬁcients from the regression models, outlined in the sec-
tions that follow.
Cognitive measures
Relationship with resident-completed EQ-5D-5L. No
statistically signiﬁcant relationships were observed among
changes in the FAST, CDR, or CMAI measures and changes in the
resident-completed EQ-5D-5L.
Relationship with formal proxy-completed PBMs. A
statistically signiﬁcant (negative) relationship was observed be-
tween changes in both the CMAI and CDR measures and changes
in the formal-carer PBMs (EQ-5D-5L-proxy and DEMQOL-Proxy-
U). The formal-carer EQ-5D-5L-proxy also captured a change to
8 VALUE IN HEALTH - 2019FAST score 6 and FAST score 7 (indicating more cognitive and
functional impairment); however, the formal-carer DEMQOL-
Proxy-U was not responsive to any changes in FAST scores.
Relationship with informal proxy-completed
PBMs. Statistically signiﬁcant (negative) relationships were
observed between all possible changes in the FAST score and the
informal-carer EQ-5D-5L-proxy and DEMQOL-Proxy-U (with 1
exception). In the analyses of FAST scores, the magnitude of the
relationships with informal-carer PBMs was always greater than
the magnitude of the relationships with the formal-carer PBMs,
whereas for the CDR and CMAI analyses, the coefﬁcients were
always larger for the formal-carer PBMs.
Other HRQOL measures
A statistically signiﬁcant relationship was always observed
between the HRQOL measures and PBMs where completed by the
same respondent (eg, the relationship between changes in
resident-reported QOL-AD-NH and resident-reported EQ-5D-5L
was statistically signiﬁcant).
The relationship between changes in the (proxy-completed)
QUALID score and changes in the EQ-5D-5L-proxy score were also
always statistically signiﬁcant, regardless of which proxy had
completed the assessment, but this was not the case in the ana-
lyses of the relationship between QUALID and DEMQOL-Proxy-U.
Discussion
This study identiﬁed disparities in the measurement properties
of 2 different PBMs completed by up to 3 different respondents
(residents, formal-carer proxy assessors, and informal-carer proxy
assessors) about 1 individual.
How Do Proxy-Completed PBMs Compare to Resident-
Completed EQ-5D for People With Dementia?
Consistent with existing studies, we found the likelihood of
eliciting a self-completed EQ-5D response decreased substantially
with dementia severity, with nonresponse rising to four-ﬁfths of
residents with “severe dementia” (FAST score 7). In contrast, EQ-
5D-5L-proxy and DEMQOL-Proxy-U data collection via a formal-
carer proxy was feasible for almost all residents, demonstrating
the role of such proxies in eliminating a substantial risk of sample
bias if only resident-reported measures are used. However,
informal-carer proxies could be recruited for only a minority of
residents (,20%), indicating that for a care home-based sample of
people with dementia, staff member proxies would likely provide
the largest number of responses.
Our ﬁnding that resident-completed EQ-5D-5L scores were of a
greater magnitude than proxy-completed EQ-5D-5L scores was
also consistent with existing studies of dementia17-23 and some
other conditions.17 Researchers should consider any inﬂuence this
might have on the results of a trial using proxy-completed data.
In tests of criterion validity and responsiveness, which NICE
explicitly recommends for determining the appropriateness of EQ-
5D for a particular population,1 the self-completed EQ-5D-5L was
poor at reﬂecting clinically important differences and changes in
the FAST, CDR, and CMAI scores but rather better at capturing (the
resident’s own view of) quality of life (QOL-AD-NH). This is
consistent with some comparable studies involving people with
dementia that identiﬁed correlation between resident-reported
EQ-5D and QOL-AD-NH24-26 but not between resident-reported
EQ-5D and some cognitive measures (eg, the Psychogeriatric
Assessment Scale–Cognitive Impairment scale [PAS-Cog] and the
Neuropsychiatric Inventory-Questionnaire [NPI-Q]).4,18,24,26Our ﬁnding that the EQ-5D-5L-proxy and DEMQOL-Proxy-U
did capture changes in the FAST, CDR, and CMAI may justify
their use in research, especially if the intervention under investi-
gation is expected to affect these more objective, cognitive aspects
of health. Nevertheless, we also found the formal-carer–
completed and informal-carer–completed EQ-5D-5L-proxy and
DEMQOL-Proxy-U were unable to capture the residents’ percep-
tions of their own quality of life (as measured by the QOL-AD-NH),
despite adequately capturing the proxies’ views of the residents’
quality of life (QUALID). This might reﬂect discrepancies between
proxy views and resident views of the impact that a tangible
decline in cognition, functional abilities, or clinical aspects of
health has on quality of life. Perhaps the resident did not notice
that decline or felt it did not unduly interfere with his or her
quality of life. For instance, despite declining physical mobility, a
resident might still enjoy full access to the things he or she values
because of support from staff and/or aids (eg, wheelchairs or
hoists). The resident’s reference point, when considering what is
meant by “usual activities,” for example, may also differ from that
of the resident’s proxy, who might more likely think about
younger, healthier people in the general population than fellow
residents in the care home. Hence, without a fuller understanding
of the degree to which residents’ cognitive impairments had
prevented them from being able to appreciate their current situ-
ation reliably, researchers (and NICE) face a considerable challenge
in terms of deciding when it is desirable to give less weight to a
resident’s own stated views. After all, this could lead to in-
terventions deemed of value by proxies being prioritized over
other interventions that would have greater impact on those as-
pects of HRQOL residents themselves say they value the most.
If Researchers Opt for Proxy-Completed PBMs, Does It
Matter Which They Use?
We found that EQ-5D-5L-proxy and DEMQOL-Proxy-U were
generally weak or poor substitutes for measuring utility. Regard-
less of which proxy completed it, the EQ-5D-5L-proxy was typi-
cally more responsive than the DEMQOL-Proxy-U to changes in
CDR, FAST, and CMAI. This probably reﬂects the relative content of
the measures: EQ-5D examines the frequency and severity of
symptoms and functional impairment directly, whereas DEQMOL-
Proxy-U has a broader focus on the emotional impact of dementia
across wider QOL domains. Nevertheless, because DEMQOL-
Proxy-U was no better than the EQ-5D-5L-proxy at reﬂecting as-
pects of resident-reported HRQOL included in the QOL-AD-NH,
this study provides no substantive evidence to justify using
DEMQOL-Proxy-U over the default (and perhaps more straight-
forward27) EQ-5D-5L proxy.
We also identiﬁed a moderate correlation between the
informal-carer-completed EQ-5D-5L-proxy and DEMQOL-Proxy-U,
with the DEMQOL-Proxy-U providing higher utility scores espe-
cially at lower levels. These results closely resemble those of the 2
comparable Australian studies4,9 (eg, we reported rho = 0.386,
versus 0.389 in 1 of the Australian studies, and a mean difference
of 0.214 versus 0.202). These results might have arisen because the
EQ-5D-5L has a much lower bound than the DEMQOL-Proxy-U
(20.285 vs 0.363, respectively).
Comparison With Existing Studies
Three existing (repeated) cross-sectional studies compared
various combinations of resident-completed and proxy-completed
versions of the EQ-5D and the DEMQOL in Britain19 or Australia.4,9
In contrast to our study, these included people without dementia4
or people who were restricted to unrepresentative subgroups (eg,
people recently hospitalized9 or with signiﬁcant depressive
-- 9symptoms).19 None of these studies compared formal-carer with
informal-carer proxies or DEMQOL-Proxy-U with other quality of
life measures (QOL-AD-NH and QUALID), and 2 of the studies did
not compare self- and proxy-responses for the same residents.
Our study uniquely collected data from 2 dementia-speciﬁc
scales of cognitive and functional impairment (FAST and CDR),
rather than using more general cognition or mental health mea-
sures (eg, the Mini-Mental State Exam [MMSE] or the PAS-Cog),
and included residents with the full range of dementia severity.
Larger sample sizes, repeated measures, and/or longer follow-up
periods also enabled analyses of responsiveness that likely sup-
port more robust causal inference than can be done with cross-
sectional comparisons.Limitations
Some caution is necessary when comparing person-speciﬁc
utility scores measured at the same time point because each
assessor completed the PBM questionnaires at different times
within a 2-week window and because by design the EQ-5D-5L
(which measures “health today”) and the DEMQOL (which mea-
sures health “the past week”) assess HRQOL over different time
periods (Table 1).
Although this study included multiple utility measures for each
resident, it did not include the (resident-reported) DEMQOL-U
(owing to concerns about research burden) or broader capability
measures (eg, ICECAP-O [ICEpop CAPability measure for Older
people]28).
Implications and Future Research
This study can inform decisions about how to measure utility
in studies of people with dementia depending, for example, on the
functional or cognitive aspects of the HRQOL that researchers wish
to capture and on the severity of dementia in trial participants. A
future study could collect the quantitative PBM data alongside
immediate qualitative interviewing to better understand reasons
for observed discrepancies between resident- and proxy-rated
utility. Given the difﬁculties of collecting utility data from resi-
dents (when they were unable) and proxies (because of recruit-
ment challenges) in this study, as well as discrepancies between
utility measures, researchers would be well advised to try to
collect PBM data from both individuals and their proxies. Future
work could establish how to improve the participation of proxies
in trials and develop more speciﬁc guidance on when particular
utility measures should be used, based, for instance, on dementia
severity. This requires more information on the degree to which
discrepancies between proxy- and resident-reported outcomes
arise because residents are no longer able to judge their own
situation reliably, for instance, and more information on which
particular improvements in functional or cognitive aspects of
HRQOL are most valued by payors. A potential focus of future
research could be to combine different utility scores to provide a
more complete utility measure that utilizes the insights provided
by residents as well as their proxies, perhaps by “adjusting” the
scores of one using the score provided by another.
The observed relationships between the utility scores and
(non-PBM) cognitive measures could also be used to inform health
state utility parameters associated with several different clinical
measures in economic models, by indicating the utility decrement
associated with different (worsening) dementia severity, and to
inform imputation techniques in trials where some utility mea-
sures are missing.Conclusion
There are multiple strategies to capture health state utility in
people with dementia. Choice of strategy has a nontrivial impact
on the utility values obtained, and these will potentially have an
impact on economic evaluation results. The results presented here
can inform choice of utility capture strategy. Future research
should explore how to combine utility data from multiple
different sources to prevent data loss and to retain the patient’s
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